These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 12364475

  • 1. Determination of galectin-3 messenger ribonucleic Acid overexpression in papillary thyroid cancer by quantitative reverse transcription-polymerase chain reaction.
    Bernet VJ, Anderson J, Vaishnav Y, Solomon B, Adair CF, Saji M, Burman KD, Burch HB, Ringel MD.
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4792-6. PubMed ID: 12364475
    [Abstract] [Full Text] [Related]

  • 2. Galectin-3 messenger ribonucleic acid and protein are expressed in benign thyroid tumors.
    Martins L, Matsuo SE, Ebina KN, Kulcsar MA, Friguglietti CU, Kimura ET.
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4806-10. PubMed ID: 12364477
    [Abstract] [Full Text] [Related]

  • 3. Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas.
    Saggiorato E, Aversa S, Deandreis D, Arecco F, Mussa A, Puligheddu B, Cappia S, Conticello S, Papotti M, Orlandi F.
    J Endocrinol Invest; 2004 Apr; 27(4):311-7. PubMed ID: 15233548
    [Abstract] [Full Text] [Related]

  • 4. Galectin-3 is a presurgical marker of human thyroid carcinoma.
    Orlandi F, Saggiorato E, Pivano G, Puligheddu B, Termine A, Cappia S, De Giuli P, Angeli A.
    Cancer Res; 1998 Jul 15; 58(14):3015-20. PubMed ID: 9679965
    [Abstract] [Full Text] [Related]

  • 5. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.
    Chiappetta G, Tallini G, De Biasio MC, Manfioletti G, Martinez-Tello FJ, Pentimalli F, de Nigris F, Mastro A, Botti G, Fedele M, Berger N, Santoro M, Giancotti V, Fusco A.
    Cancer Res; 1998 Sep 15; 58(18):4193-8. PubMed ID: 9751634
    [Abstract] [Full Text] [Related]

  • 6. Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue.
    Cvejic D, Savin S, Paunovic I, Tatic S, Havelka M, Sinadinovic J.
    Anticancer Res; 1998 Sep 15; 18(4A):2637-41. PubMed ID: 9703921
    [Abstract] [Full Text] [Related]

  • 7. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms.
    Inohara H, Honjo Y, Yoshii T, Akahani S, Yoshida J, Hattori K, Okamoto S, Sawada T, Raz A, Kubo T.
    Cancer; 1999 Jun 01; 85(11):2475-84. PubMed ID: 10357421
    [Abstract] [Full Text] [Related]

  • 8. Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.
    Abd-El Raouf SM, Ibrahim TR.
    Pathol Res Pract; 2014 Dec 01; 210(12):971-8. PubMed ID: 25041837
    [Abstract] [Full Text] [Related]

  • 9. Decreased relative expression level of trefoil factor 3 mRNA to galectin-3 mRNA distinguishes thyroid follicular carcinoma from adenoma.
    Takano T, Miyauchi A, Yoshida H, Kuma K, Amino N.
    Cancer Lett; 2005 Feb 28; 219(1):91-6. PubMed ID: 15694668
    [Abstract] [Full Text] [Related]

  • 10. Molecular classification of thyroid nodules by cytology.
    Pagedar NA, Chen DH, Wasman JK, Savvides P, Schluchter MD, Wilhelm SM, Lavertu P.
    Laryngoscope; 2008 Apr 28; 118(4):692-6. PubMed ID: 18094649
    [Abstract] [Full Text] [Related]

  • 11. Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms.
    Mehrotra P, Okpokam A, Bouhaidar R, Johnson SJ, Wilson JA, Davies BR, Lennard TW.
    Histopathology; 2004 Nov 28; 45(5):493-500. PubMed ID: 15500653
    [Abstract] [Full Text] [Related]

  • 12. Galectin-3 and oncofetal-fibronectin expression in thyroid neoplasia as assessed by reverse transcription-polymerase chain reaction and immunochemistry in cytologic and pathologic specimens.
    Giannini R, Faviana P, Cavinato T, Elisei R, Pacini F, Berti P, Fontanini G, Ugolini C, Camacci T, De Ieso K, Miccoli P, Pinchera A, Basolo F.
    Thyroid; 2003 Aug 28; 13(8):765-70. PubMed ID: 14558920
    [Abstract] [Full Text] [Related]

  • 13. [Expression of cytokeratin19, galectin-3 and HBME-1 in thyroid lesions and their differential diagnoses].
    Teng XD, Wang LJ, Yao HT, Li J, Ding W, Yan LP.
    Zhonghua Bing Li Xue Za Zhi; 2004 Jun 28; 33(3):212-6. PubMed ID: 15256110
    [Abstract] [Full Text] [Related]

  • 14. Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue.
    Fernández PL, Merino MJ, Gómez M, Campo E, Medina T, Castronovo V, Sanjuán X, Cardesa A, Liu FT, Sobel ME.
    J Pathol; 1997 Jan 28; 181(1):80-6. PubMed ID: 9072007
    [Abstract] [Full Text] [Related]

  • 15. Expression of galectin-3 in normal and malignant thyroid tissue by quantitative PCR and immunohistochemistry.
    Feilchenfeldt J, Tötsch M, Sheu SY, Robert J, Spiliopoulos A, Frilling A, Schmid KW, Meier CA.
    Mod Pathol; 2003 Nov 28; 16(11):1117-23. PubMed ID: 14614051
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic value of preoperative DNA measurement on FNA in benign and malignant thyroid neoplasm.
    Perigli G, Cicchi P, Cianchi F, Artusi R, Olivari D, Caldini A, Cortesini C.
    J Exp Clin Cancer Res; 1998 Mar 28; 17(1):113-6. PubMed ID: 9646245
    [No Abstract] [Full Text] [Related]

  • 17. Differential reactivity for galectin-3 in Hürthle cell adenomas and carcinomas.
    Nascimento MC, Bisi H, Alves VA, Longatto-Filho A, Kanamura CT, Medeiros-Neto G.
    Endocr Pathol; 2001 Mar 28; 12(3):275-9. PubMed ID: 11740048
    [Abstract] [Full Text] [Related]

  • 18. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.
    Savin S, Cvejic D, Isic T, Paunovic I, Tatic S, Havelka M.
    Hum Pathol; 2008 Nov 28; 39(11):1656-63. PubMed ID: 18657294
    [Abstract] [Full Text] [Related]

  • 19. Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications.
    Xu XC, el-Naggar AK, Lotan R.
    Am J Pathol; 1995 Sep 28; 147(3):815-22. PubMed ID: 7677193
    [Abstract] [Full Text] [Related]

  • 20. Cyclin D1 in well differentiated thyroid tumour of uncertain malignant potential.
    Lamba Saini M, Weynand B, Rahier J, Mourad M, Hamoir M, Marbaix E.
    Diagn Pathol; 2015 Apr 18; 10():32. PubMed ID: 25907675
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.